'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'
Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously developed four-in-one immunity shot.
The biotech company's revenues had fallen to as low as Rs 50 cr.